Literature DB >> 9416412

Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome.

C E Cox1, M Hyacinthe, R J Gonzalez, G Lyman, D Reintgen, N N Ku, M S Miller, H Greenberg, S V Nicosia.   

Abstract

BACKGROUND: Breast conservation therapy is controversial for ductal carcinoma in situ (DCIS) due to recently reported high recurrence rates. We believe that cytologic evaluation of lumpectomy margins improves efficiency and leads to a lower recurrence rate following lumpectomy for DCIS.
METHODS: A prospectively accrued database of 1255 breast cancer patients at the H. Lee Moffitt Cancer Center and Research Institute was found to have 218 patients with DCIS (17.4%). Of those 218 cases, 114 were treated with lumpectomy, axillary dissection, and radiation therapy; the remaining 104 patients were treated with mastectomy with or without reconstruction. Imprint cytology was used to evaluate all lumpectomy margins. Permanent sections and imprint cytology were reviewed by the same pathologist.
RESULTS: All lumpectomy specimens (116 tumors in 114 patients) were evaluated. The median follow up was 57.5 months (range 2-110 months). One hundred and three patients with 104 tumors were selected on the basis of pure DCIS (with or without microinvasion), and treated with lumpectomy, axillary dissection and radiation therapy. Of the 104 tumors utilizing attempted breast conservation therapy, 7 (6.6%) required mastectomy. There were 6 recurrences (6.1%) with a median time for recurrence of 47.5 months (range 27-85 months); four recurrences were comedo and two were noncomedo at original diagnosis.
CONCLUSIONS: The determination of lumpectomy margins in DCIS patients using imprint cytology leads to an overall recurrence rate of 6.1% with reduction in operative time, and re-excision rate. Significant recurrence rates were associated with microinvasion and multifocal tumors (28%) versus simple DCIS at 5 years. Breast conservation therapy and surgical margin determination with imprint cytology for DCIS is a cost-effective and reliable method of treatment for simple DCIS.

Entities:  

Mesh:

Year:  1997        PMID: 9416412     DOI: 10.1007/bf02303749

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Optical assessment of tumor resection margins in the breast.

Authors:  J Quincy Brown; Torre M Bydlon; Lisa M Richards; Bing Yu; Stephanie A Kennedy; Joseph Geradts; Lee G Wilke; Marlee Junker; Jennifer Gallagher; William Barry; Nimmi Ramanujam
Journal:  IEEE J Sel Top Quantum Electron       Date:  2010-03-01       Impact factor: 4.544

Review 2.  Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.

Authors:  Tatyana Shamliyan; Shi-Yi Wang; Beth A Virnig; Todd M Tuttle; Robert L Kane
Journal:  J Natl Cancer Inst Monogr       Date:  2010

3.  Quantitative automated image analysis system with automated debris filtering for the detection of breast carcinoma cells.

Authors:  David T Martin; Sergio Sandoval; Casey N Ta; Manuel E Ruidiaz; Maria Jose Cortes-Mateos; Davorka Messmer; Andrew C Kummel; Sarah L Blair; Jessica Wang-Rodriguez
Journal:  Acta Cytol       Date:  2011-04-27       Impact factor: 2.319

Review 4.  Intraoperative imprint cytology and frozen section pathology for margin assessment in breast conservation surgery: a systematic review.

Authors:  Karla Esbona; Zhanhai Li; Lee G Wilke
Journal:  Ann Surg Oncol       Date:  2012-07-31       Impact factor: 5.344

Review 5.  Preoperative localization and surgical margins in conservative breast surgery.

Authors:  F Corsi; L Sorrentino; D Bossi; A Sartani; D Foschi
Journal:  Int J Surg Oncol       Date:  2013-08-05

6.  Computerized decision support system for intraoperative analysis of margin status in breast conservation therapy.

Authors:  Manuel E Ruidíaz; Sarah L Blair; Andrew C Kummel; Jessica Wang-Rodriguez
Journal:  ISRN Surg       Date:  2012-11-25

7.  Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference.

Authors:  Jeffrey Landercasper; Deanna Attai; Dunya Atisha; Peter Beitsch; Linda Bosserman; Judy Boughey; Jodi Carter; Stephen Edge; Sheldon Feldman; Joshua Froman; Caprice Greenberg; Cary Kaufman; Monica Morrow; Barbara Pockaj; Melvin Silverstein; Lawrence Solin; Alicia Staley; Frank Vicini; Lee Wilke; Wei Yang; Hiram Cody
Journal:  Ann Surg Oncol       Date:  2015-07-28       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.